Unit | Clinical Operations
Over 20 Years' Experience as Clinical Trials Service Provider
Swiss TPH has extensive expertise in clinical trial service provision, with a successful track record of operating and facilitating research in resource-constraint settings for over 20 years. We understand the barriers to conducting clinical trials in difficult settings and offer strategic, customised solutions with a high level of flexibility. We appreciate the intricacies of strategic planning in these settings and aim to deliver the highest quality data for clinical trials tailored to each unique project.
We do this through:
⇒ Local know-how of regional context
⇒ Understanding the patient pathway in various settings
⇒ Academic and scientific innovation
⇒ Clinical expertise and management
⇒ Global network of partners and collaborators
We propose study designs and monitoring solutions to promote evidence-based practices that lead to meaningful, sustainable and effective outputs. By working with healthcare providers in an open, transparent manner, we enrich our local understanding and thus enhance the quality to deliver customer-focused clinical trials.
Head of Unit
+41612848966
elisabeth.reus@swisstph.ch
Our Philosophy
Access to effective, evidence-based medicine is a fundamental right, not a privilege.
Promoting evidence-based medicine and conducting clinical research requires customised and optimised solutions with a fully integrated, robust quality system at each level – starting at the earliest development stages through to final implementation. Provision of the highest quality and data integrity will allow the downstream use of collected data for the evaluation of drugs, diagnostics and vaccines, ultimately enabling FDA or EMA accreditation of successful candidates, support evidence-based medicine practices and contribute to national and international disease management guidelines. Our dedicated team is committed to these principles.
Impact Stories: “It is a privilege to be able to bring science to the bedside” – Elisabeth Reus on the launch of a new malaria clinical trial in the DRC
Our Team - 11 Nationalities, 150 Years of Combined Expertise
We are a global, experienced, multidisciplinary, multilingual team comprised of scientists, clinicians, and experienced medical and administrative staff. Through our combined clinical, research and local expertise with long-standing partnerships in an extensive global network of regional collaborators, we aim to deliver the highest-quality consumer-focused clinical trial results.
Our Study Sites
Selected Projects
All ProjectsLatest Publications
All PublicationsBeynon F et al. The Tools for Integrated Management of Childhood Illness (TIMCI) study protocol: a multi-country mixed-method evaluation of pulse oximetry and clinical decision support algorithms. Glob Health Action. 2024;17:2326253. DOI: 10.1080/16549716.2024.2326253
Chernet A, Paris D.H, Alchalabi L, Utzinger J, Reus E. Public and patient involvement in migration health research: Eritrean and Syrian refugees' and asylum seekers' views in Switzerland. Healthcare (Basel). 2024;12(16):1654. DOI: 10.3390/healthcare12161654
Nebie E.I, van Eeuwijk P, Sawadogo H.N, Reus E, Utzinger J, Burri C. Operational differences between product development partnership, pharmaceutical industry, and investigator initiated clinical trials. Trop Med Infect Dis. 2024;9(3):56. DOI: 10.3390/tropicalmed9030056
Mäser P et al. Key contributions by the Swiss Tropical and Public Health Institute towards new and better drugs for tropical diseases. Chimia (Aarau). 2023;77(9):593-606. DOI: 10.2533/chimia.2023.593
Mesu V.K.B.K et al. Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. Lancet Infect Dis. 2023;23(4):463-470. DOI: 10.1016/S1473-3099(22)00660-0